Dr Leah Iles is a cardiologist at The Alfred Hospital in Melbourne, specialising in heart failure and cardiac imaging. She is currently the clinical lead for Echocardiography at The Alfred. Her doctoral studies focused on myocardial fibrosis in heart failure and the utility of MRI in assessment.

Dr Sarah Gutman MBBS BMedSci FRACP PhD is Head of Cardiovascular MRI at The Baker Heart and Diabetes Institute and a cardiologist at The Alfred and St. Vincent's hospitals. She specialises in heart failure, transplantation and non-invasive imaging (including cardiac MRI, cardiac CT and echocardiography). Dr. Gutman’s research interests include the use of cardiac MRI in risk stratification of heart failure patients and treating obesity in patients with heart failure.

A/Prof Rebecca Kozor is a physician-researcher with roles as a consultant cardiologist at Royal North Shore Hospital Sydney and as Associate Professor at the University of Sydney. She has specialist expertise in cardiac imaging, particularly cardiovascular magnetic resonance imaging.

A/Prof Raj Puranik MB BS PhD FRACP was a Neil Hamilton Fairley NHMRC/NHFA Post-doctoral Fellow in cardiovascular magnetic resonance. He is now a Consultant in Cardiovascular MR at RPAH, Specialist MRI, Westmead Children's Hospital and the University of Sydney. His training was completed at the Centre for Cardiovascular MR at University College London and Great Ormond St Hospital for Children from 2006 to 2008. Since A/Prof Puranik’s return from London, he has established CMRS which has developed research programs and has performed 8000 cardiac scans and trained over 40 clinical or research fellows over the past 10years. He has published >100 peer-reviewed manuscripts.

Professor Andrew Taylor is a full-time a consultant cardiologist with the Department of Cardiovascular Medicine, Alfred Hospital, and a NHMRC Leadership Investigator at Monash University. He works as a clinician in the Heart Failure and Transplant Unit, and has a strong research interest in advanced cardiac imaging techniques and heart failure. In 2002, Prof. Taylor carried out a year of post doctoral research in Berlin, Germany, in cardiovascular magnetic resonance (CMR) imaging, and he heads both the CMR and cardiac CT angiography services at the Alfred Hospital. Prof. Taylor has been an invited speaker in cardiac imaging at numerous local and international cardiology meetings, and he has published over 150 peer-reviewed journal articles, including in the highest ranking cardiology journals Circulation and JACC.

Professor John Greenwood is the Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor at Melbourne University, Monash University, and also the University of Leeds, UK. As a consultant cardiologist for 20 years, he has specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging. Professor Greenwood underwent his clinical and academic training in Leeds, UK, and in addition underwent specialist training in coronary intervention in Toulouse, France and Cardiovascular Magnetic Resonance (CMR) imaging at the Royal Brompton Hospital, London. His main focus of research has been the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of pulse sequence development and validation through large scale clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease. In particular, early phase clinical trials of drugs and devices to reduce infarct size in the setting of acute myocardial infarction. He is the immediate Past-President of the British Cardiovascular Society (BCS; 2021-2024) and a member of Council of The Royal College of Physicians, London. He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008, and became BSCMR President (2018-2020). He is past-Chair of the SCMR clinical trials committee (2015-2017) and member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. He was a winner of the SCMR Gold Medal in 2023 and Associate Editor of JCMR (2017-2023). He is a member of the ESC Cardio-policy group (2022-2024), ESC Advocacy Committee (2021-current) and a past member of the Assembly of International Governors of the ACC (2021-2024). He has supervised/co-supervised to completion ~30 MD/PhD students and has ~400 peer-reviewed publications, including many in NEJM, Lancet, JAMA, Circulation, JACC and EHJ.

Joseph Selvanayagam is an internationally recognised authority in cardiac imaging. He holds the Chair of Cardiovascular Medicine at Flinders University and is a Senior Clinical Cardiologist at Flinders Medical Centre, where he is the Director of Non-Invasive Cardiac Imaging. As the Director of Cardiac Imaging Research Group (CIRG), SA Health and Medical Research Institute (SAHMRI), he leads a group with an international reputation in randomised clinical trials, cardiomyopathy and cardiac imaging research. He graduated with first class Honours from the University of Adelaide in 1995, obtained his FRACP (Cardiology) in 2002 and his PhD from Oxford University (DPhil) in 2005. For his doctoral and post-doctoral work he received the Wellcome Trust (UK) Cardiovascular Research Fellowship, UK Overseas Research Students Awards Scheme and the Intermediate Research Fellowship award from the British Heart Foundation. In addition during this time, he received several national and international awards, including a merit award from Oxford University, and the Samuel Levine Finalist Award of the American Heart Association. Over the course of his research career he has attracted more than 28million AUD in grant funding. Prof Selvanayagam has published > 450 peer-reviewed manuscripts/abstracts/book chapters with an h-index of 48 and >16000 citations [source: Scopus].